Jennifer Brown, M.D., Director of the CLL Center of the Division of Hematologic Malignancies at Dana-Farber Cancer Institute and an Associate Professor of Medicine at Harvard Medical School in Boston, Massachusetts discusses Duvelisib: New Treatment For Relapse Refractory CLL at Lymphoma & Myeloma on October 18, 2018.
Duvelisib: New Treatment for Relapse Refractory CLL
